Significance of HLA in Graves' Disease and Graves' Orbitopathy in Asian and Caucasian Populations - a Systematic Review

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2023 Oct 16

PMID 37841270

Authors

Magdalena Stasiak

Bartlomiej Stasiak

Katarzyna Zawadzka-Starczewska

Andrzej Lewinski

Affiliations

Soon will be listed here.

Abstract

Introduction: Graves' disease (GD) and Graves' orbitopathy (GO) development were suspected to be HLA-related in both Asian and Caucasian populations. However, most studies were performed with application of serological methods or low resolution genetic typing, which led to inconsistent results even among the same population. The present review is intended to summarize the state-of-art knowledge on the HLA significance in GD and GO in Asians and Caucasians, as well as to find the most significant alleles for each of the populations.

Methods: PubMed was searched for relevant articles using the following search terms: HLA plus thyroid-associated ophthalmopathy or Graves' disease or Graves' orbitopathy or thyroid eye disease or thyroid-associated orbitopathy.

Results: In Asian population GD was found to be associated mostly with , , , , , and , while , , are potentially protective. can be considered associated with increased risk of GO in Asians, while may play protective role. In Caucasians, , , are associated with GD risk while , may be protective. Significance of HLA in the course of GD and novel aspects of HLA amino acid variants and potential HLA-based treatment modalities were also discussed.

Citing Articles

Crossroads between Skin and Endocrine Glands: The Interplay of Lichen Planus with Thyroid Anomalies.

Radu A, Carsote M, Nistor C, Dumitrascu M, Sandru F Biomedicines. 2024; 12(1).

PMID: 38255184 PMC: 10813575. DOI: 10.3390/biomedicines12010077.

References

Allannic H, Fauchet R, Lorcy Y, Heim J, Gueguen M, Leguerrier A . HLA and Graves' disease: an association with HLA-DRw3. J Clin Endocrinol Metab. 1980; 51(4):863-7. DOI: 10.1210/jcem-51-4-863. View

Li C, Osman R, Menconi F, Concepcion E, Tomer Y . Cepharanthine blocks TSH receptor peptide presentation by HLA-DR3: Therapeutic implications to Graves' disease. J Autoimmun. 2020; 108:102402. PMC: 7819272. DOI: 10.1016/j.jaut.2020.102402. View

Zamani M, Spaepen M, Bex M, Bouillon R, Cassiman J . Primary role of the HLA class II DRB1*0301 allele in Graves disease. Am J Med Genet. 2001; 95(5):432-7. DOI: 10.1002/1096-8628(20001218)95:5<432::aid-ajmg5>3.0.co;2-7. View

Dong R, Kimura A, Okubo R, Shinagawa H, Tamai H, Nishimura Y . HLA-A and DPB1 loci confer susceptibility to Graves' disease. Hum Immunol. 1992; 35(3):165-72. DOI: 10.1016/0198-8859(92)90101-r. View

Simmonds M, Howson J, Heward J, Carr-Smith J, Franklyn J, Todd J . A novel and major association of HLA-C in Graves' disease that eclipses the classical HLA-DRB1 effect. Hum Mol Genet. 2007; 16(18):2149-53. DOI: 10.1093/hmg/ddm165. View

Stasiak M, Lewinski A . Strong Correlation between HLA and Clinical Course of Subacute Thyroiditis-A Report of the Three Siblings. Genes (Basel). 2020; 11(11). PMC: 7693567. DOI: 10.3390/genes11111282. View

Frecker M, STENSZKY V, Balazs C, Kozma L, Kraszits E, Farid N . Genetic factors in Graves' ophthalmopathy. Clin Endocrinol (Oxf). 1986; 25(5):479-85. DOI: 10.1111/j.1365-2265.1986.tb03599.x. View

Villanueva R, Inzerillo A, Tomer Y, Barbesino G, Meltzer M, Concepcion E . Limited genetic susceptibility to severe Graves' ophthalmopathy: no role for CTLA-4 but evidence for an environmental etiology. Thyroid. 2000; 10(9):791-8. DOI: 10.1089/thy.2000.10.791. View

Lane L, Kus A, Bednarczuk T, Bossowski A, Daroszewski J, Jurecka-Lubieniecka B . An Intronic HCP5 Variant Is Associated With Age of Onset and Susceptibility to Graves Disease in UK and Polish Cohorts. J Clin Endocrinol Metab. 2020; 105(9). PMC: 7382372. DOI: 10.1210/clinem/dgaa347. View

10.

Bartalena L, Tanda M . Current concepts regarding Graves' orbitopathy. J Intern Med. 2022; 292(5):692-716. PMC: 9796560. DOI: 10.1111/joim.13524. View

11.

Di Mario U, Vitillo M, Perfetti R, Mancuso M, Morellini M, Cappellacci S . Humoral and cellular immunological factors as possible markers of clinical relapse in HLA-typed Graves' patients followed with time. Horm Metab Res. 1989; 21(5):267-71. DOI: 10.1055/s-2007-1009209. View

12.

Morshed S, Latif R, Davies T . Signal responses to neutral TSH receptor antibody - A cycle of damage in the pathophysiology of Graves' disease. J Autoimmun. 2023; 136:103012. DOI: 10.1016/j.jaut.2023.103012. View

13.

Vejrazkova D, Vcelak J, Vaclavikova E, Vankova M, Zajickova K, Vrbikova J . Recurrence of Graves' Disease: What Genetics of HLA and Can Tell Us. Front Endocrinol (Lausanne). 2021; 12:761077. PMC: 8650699. DOI: 10.3389/fendo.2021.761077. View

14.

Wongsurawat T, Nakkuntod J, Charoenwongse P, Snabboon T, Sridama V, Hirankarn N . The association between HLA class II haplotype with Graves' disease in Thai population. Tissue Antigens. 2006; 67(1):79-83. DOI: 10.1111/j.1399-0039.2005.00498.x. View

15.

Wilson R, McKillop J, Henderson N, Pearson D, Thomson J . The ability of the serum thyrotrophin receptor antibody (TRAb) index and HLA status to predict long-term remission of thyrotoxicosis following medical therapy for Graves' disease. Clin Endocrinol (Oxf). 1986; 25(2):151-6. DOI: 10.1111/j.1365-2265.1986.tb01676.x. View

16.

Radziszewski M, Kus A, Bednarczuk T . Genotype-phenotype correlations in Graves' disease. Best Pract Res Clin Endocrinol Metab. 2023; 37(2):101745. DOI: 10.1016/j.beem.2023.101745. View

17.

Chaudhary S, Dogra V, Walia R . Four cases of Graves' disease following viral vector severe acute respiratory syndrome corona virus-2 (SARS-CoV-2) vaccine. Endocr J. 2022; 69(12):1431-1435. DOI: 10.1507/endocrj.EJ22-0208. View

18.

Cho W, Jung M, Choi E, Choi H, Kim T, Suh B . Association of HLA alleles with autoimmune thyroid disease in Korean children. Horm Res Paediatr. 2011; 76(5):328-34. DOI: 10.1159/000331134. View

19.

Martin S, Dutescu M, Sirbu A, Barbu C, Albu A, Florea S . The clinical value of human leukocyte antigen HLA-DRB1 subtypes associated to Graves' disease in Romanian population. Immunol Invest. 2014; 43(5):479-90. DOI: 10.3109/08820139.2014.886261. View

20.

Liao W, Liu T, Cheng C, Chou Y, Wang T, Chang Y . Analysis of Variants and Graves' Disease and Its Comorbidities Using a High Resolution Imputation System to Examine Electronic Medical Health Records. Front Endocrinol (Lausanne). 2022; 13:842673. PMC: 8936090. DOI: 10.3389/fendo.2022.842673. View